DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 8.05 0.17%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)

99.23 1.23 (1.26%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MDVN $99.23 1.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $98.54
Previous Close $98.00
Daily Range $92.18 - $100.86
52-Week Range $54.37 - $117.23
Market Cap $7.7B
P/E Ratio 69.01
Dividend (Yield) $0.00 (0.0%)
Volume 588,193
Average Daily Volume 1,116,742
Current FY EPS $2.56





Medivation, Inc. (MDVN) Description

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website:

News & Commentary

The Most Disappointing Clinical Failures in 2014

Three Motley Fool contributors tell us what they think were the biggest drug trial failures this year.

Medivation Licenses CureTech's Cancer Drug Pidilizumab - Analyst Blog

William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

Medivation (MDVN): Today's Weak On High Volume Stock

3 Large Cap Biotech Stocks That Could Surprise Investors in 2015

Celgene Corp, Biogen Idec, and Medivation Inc. offer catalysts that could allow them to outpace estimates next year.

These Biotech Stocks Are Growing Even Faster Than Gilead Sciences

Medivation Inc. and Pharmacyclics are posting even faster revenue growth than Gilead Sciences.

The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?

In this week's Industry Focus, our analysts discuss their favorites of the successful 2014 healthcare large-cap stocks.

Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer

Astellas-Medivation Reveal Data on Xtandi for Breast Cancer - Analyst Blog

Top Healthcare Stocks for 2014

These 10 stocks were the top large-cap performers in healthcare during 2014.

See More MDVN News...

MDVN's Top Competitors

MDVN $99.23 (1.26%)
Current stock: MDVN
TMO $126.79 (0.10%)
Current stock: TMO
ILMN $186.22 (1.48%)
Current stock: ILMN
WAT $114.54 (0.18%)
Current stock: WAT